Solvias and Enzymicals join forces in contract research, development and sustainable manufacturing.

24. November 2021

Solvias AG one of the largest independent analytical testing, contract research, development and manufacturing companies, today announced a non-exclusive partnership with Enzymicals AG, one of the most experienced companies in Germany for in-vitro biosynthesis with biocatalytic process development and up-scaling expertise. This will enable customers of both partners access to alternative synthetic technology platforms for chemocatalysis and biocatalysis.